| 1681 |
LUCIAMB |
AMBRISENTAN 5 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1315/25 |
2025-04-21 |
2030-04-20 |
View |
| 1682 |
LUCIANAGRE |
ANAGRELIDE 0.5 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF THROMBOCYTHEMIA, SECONDARY TO MYELOPROLIFERATIVE NEOPLASMS, TO REDUCE THE ELEVATED PLATELET COUNT AND RISK OF THROMBOSIS AND TO AMELIORATE ASSOCATED SYMPTOMS INCLUDING THROMBO-HEMORRHAGIC EVENTS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 1180/24 |
22-AUG-2024 |
21-AUG-2027 |
View |
| 1683 |
LUCIANAM |
ANAMORELIN 50 MG |
TABLET |
BOTTLE |
TO TREAT CACHEXIA PATIENTS WITH UNRESECTABLE ADVANCED AND RECURRENT NON SMALL CELL LUNG CANCER, GASTRIC CANCER, PANCREATIC CANCER AND COLORECTAL CANCER. |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
02 L 1063/24 |
20-FEB-2024 |
19-FEB-2027 |
View |
| 1684 |
LUCIAPLE |
ALPELISIB 150 MG |
TABLET |
BOTTLE |
IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF POSTMENOPAUSUAL WOMEN, AND MEN WITH HORMONE RECEPTOR POSITIVE, HYMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE, PIK3CA MUTED, ADVANCED OR METASTATIC BREAST CANCER. |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1076/24 |
14-MAR-2023 |
13-MAR-2027 |
View |
| 1685 |
LUCIAPRO |
APROCITENTAN 12.5 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF HYPERTENSION IN COMBINATION WITH OTHER ANTIHYPERTENSIVE DRUG, TO LOWER BLOOD PRESSURE IN ADULT PATIENTS WHO ARE NOT ADEQUATELY CONTROLLED ON OTHER DRUGS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 1181/24 |
22-AUG-2024 |
21-AUG-2027 |
View |
| 1686 |
LUCIASC |
ASCIMINIB HCL EQ.TO ASCIMINIB 40 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA (PH+CML) IN CHRONIC PHASE, PREVIOUSLY TREATED WITH TWO OR MORE TYROSINE KINASE INHIBITORS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
10 L 1034/23 |
30-OCT-2023 |
29-OCT-2026 |
View |
| 1687 |
LUCIAVAP |
AVAPRITINIB 100 MG |
TABLET |
BOTTLE |
GASTROINTESTINAL STROMAL TUMOR, ADVANCED SYSTEMIC MASTOCYTOSIS, INDOLENT SYSTEMIC MASTOCYTOSIS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
02 L 1296/25 |
2025-04-21 |
2030-04-20 |
View |
| 1688 |
LUCIAVAT |
AVATROMBOPAG MALEATE EQ.TO AVATROMBOPAG 20 MG |
TABLET |
BOTTLE |
FOR THE TREAMENT OF THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC LIVER DISEAE WHO ARE SCHEDULED TO UNDERGO A PROCEDURE |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 0959/23 |
19-APR-2023 |
18-APR-2026 |
View |
| 1689 |
LUCIAXI |
AXITINIB 5 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA AFTER FAILURE OF ONE PRIOR SYSTEMIC THERAPY |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 1161/24 |
21-AUG-2024 |
20-AUG-2027 |
View |
| 1690 |
LUCIBARIC |
BARICITINIB 2 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARHTRITIS WHO HAVE HAD AN INADEQUATE RESPONSE TO ONE OR MORE TNF BLOCKERS, FOR THE TREATMENT OF ADULT PATIENTS WITH SEVERE ALOPECIA AREATA. |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1311/25 |
07-APR-2025 |
06-APR-2030 |
View |
